106 related articles for article (PubMed ID: 869670)
1. CNS monoamine metabolism in bipolar affective disorder. Evaluation using a peripheral decarboxylase inhibitor.
Garfinkel PE; Warsh JJ; Stancer HC; Godse DD
Arch Gen Psychiatry; 1977 Jun; 34(6):735-9. PubMed ID: 869670
[TBL] [Abstract][Full Text] [Related]
2. The effect of a peripheral decarboxylase inhibitor (carbidopa) on monoamine and neuroendocrine function in man.
Garfinkel PE; Warsh JJ; Stancer HC; Godse DD; Brown GM; Vranic M
Neurology; 1977 May; 27(5):443-7. PubMed ID: 558549
[TBL] [Abstract][Full Text] [Related]
3. Depression: new evidence in support of biological differentiation.
Garfinkel PE; Warsh JJ; Stancer HC
Am J Psychiatry; 1979 Apr; 136(4B):535-9. PubMed ID: 426139
[TBL] [Abstract][Full Text] [Related]
4. Urinary noradrenaline and serotonin metabolites in drug-free Parkinson patients and the effect of L-dopa treatment.
Markianos M; Hadjikonstantinou M; Bistolaki E
Acta Neurol Scand; 1982 Aug; 66(2):267-75. PubMed ID: 6182730
[TBL] [Abstract][Full Text] [Related]
5. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.
Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J
Arch Gen Psychiatry; 1983 Sep; 40(9):999-1010. PubMed ID: 6193764
[TBL] [Abstract][Full Text] [Related]
6. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
[TBL] [Abstract][Full Text] [Related]
7. Catecholamine metabolism and disposition in healthy and depressed subjects.
Maas JW; Koslow SH; Davis J; Katz M; Frazer A; Bowden CL; Berman N; Gibbons R; Stokes P; Landis DH
Arch Gen Psychiatry; 1987 Apr; 44(4):337-44. PubMed ID: 3566456
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls.
Davis JM; Koslow SH; Gibbons RD; Maas JW; Bowden CL; Casper R; Hanin I; Javaid JI; Chang SS; Stokes PE
Arch Gen Psychiatry; 1988 Aug; 45(8):705-17. PubMed ID: 2456047
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a hypothalamic alteration of catecholamine metabolism in polycystic ovary syndrome.
Paradisi R; Grossi G; Venturoli S; Capelli M; Porcu E; Fabbri R; Pasquali R; Flamigni C
Clin Endocrinol (Oxf); 1988 Sep; 29(3):317-26. PubMed ID: 3251670
[TBL] [Abstract][Full Text] [Related]
10. Primary affective disorder, clinical state change, and MHPG excretion: a longitudinal study.
Pickar D; Sweeney DR; Maas JW; Heninger GR
Arch Gen Psychiatry; 1978 Nov; 35(11):1378-83. PubMed ID: 708197
[TBL] [Abstract][Full Text] [Related]
11. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
Modai I; Beigel Y; Cygielman G
J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of clorgyline on catecholamine and indoleamine metabolites in the cerebrospinal fluid of rhesus monkeys.
Garrick NA; Scheinin M; Chang WH; Linnoila M; Murphy DL
Biochem Pharmacol; 1984 May; 33(9):1423-7. PubMed ID: 6203542
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of catecholamines and indoleamines in the central nervous system of Wriggle mouse Sagami.
Kumazawa T; Adachi K; Ando K
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 93(1):167-9. PubMed ID: 2471606
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid amine metabolites in acute schizophrenia.
Post RM; Fink E; Carpenter WT; Goodwin FK
Arch Gen Psychiatry; 1975 Aug; 32(8):1063-9. PubMed ID: 1156113
[TBL] [Abstract][Full Text] [Related]
15. Biogenic amines and affective disorders.
Schildkraut JJ
Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
[No Abstract] [Full Text] [Related]
16. Effects of long-term storage on the concentrations of the unconjugated acidic metabolites of the trace amines, indoleamines and catecholamines.
Davis BA
J Chromatogr; 1988 Dec; 433():23-30. PubMed ID: 2466860
[TBL] [Abstract][Full Text] [Related]
17. Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPG.
Blombery PA; Kopin IJ; Gordon EK; Markey SP; Ebert MH
Arch Gen Psychiatry; 1980 Oct; 37(10):1095-8. PubMed ID: 7425794
[TBL] [Abstract][Full Text] [Related]
18. Urinary MHPG in subgroups of depressed patients and normal controls.
Beckmann H; Goodwin FK
Neuropsychobiology; 1980; 6(2):91-100. PubMed ID: 7354911
[TBL] [Abstract][Full Text] [Related]
19. Low level of urinary 5-hydroxyindole acetic acid (5 HIAA) in obese children having concomitantly high 3-methoxy-4-hydroxyphenyl glycol (MHPG) excretion.
Popa M; Stefănescu AM; Dumitriu L
Endocrinologie; 1989; 27(1):29-34. PubMed ID: 2474191
[TBL] [Abstract][Full Text] [Related]
20. Biogenic amine hypotheses of affective disorders.
Garver DL; Davis JM
Life Sci; 1979 Jan; 24(5):383-94. PubMed ID: 372718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
